Clinical trials in Prato – page 38

885 clinical trials in Prato, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in ItalyStudi-Clinici.it

Prato at a glance

885

clinical trials

Research sites1

Quick filters

885 trials in Prato

Open in trial search

Sjogren's syndrome

Not recruiting

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Dazodalibep
Sponsor:Horizon Therapeutics Ireland Designated Activity Company

Contact Research Centre

Sjogren's syndrome

Not recruiting

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dazodalibep
Sponsor:Amgen Inc.

Contact Research Centre

Cardiovascular disorder

Not recruiting

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Registered drugNo placebo

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Vitiligo

Not recruiting

A Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is

Investigational

A Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Zasocitinib
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Migraine

Not recruiting

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Registered drug

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Registered drug

Italy

Participants:18–64 years · 65+ years
Sponsor:Merz Therapeutics GmbH

Contact Research Centre

Migraine

Not recruiting

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Registered drug

Italy

Participants:18–64 years · 65+ years
Sponsor:Merz Therapeutics GmbH

Contact Research Centre

Psoriasis

Not recruiting

Study of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis

Registered drug

Study of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Apremilast
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Hidradenitis

Not recruiting

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Sonelokimab
Sponsor:MoonLake Immunotherapeutics AG

Contact Research Centre

Migraine

Not recruiting

Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Registered drug

Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Registered drug

Italy

Participants:18–64 years
Substances:Rimegepant
Sponsor:Pfizer Inc.

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks

Investigational

Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:VHB937
Sponsor:Novartis Pharma AG

Contact Research Centre

Obesity+1

Not recruiting

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Maridebart Cafraglutide
Sponsor:Amgen Inc.

Contact Research Centre

Other cities in Italy

The busiest research cities in the country

All 230 cities in Italy

Clinical research in Prato

What the registry says about research in the country

01 Breast Cancer Research

Extensive clinical trials focusing on hormone receptor-positive and HER2-negative breast cancer treatments, including innovative therapies and maintenance strategies.

Advanced treatment combinations
Hormone therapy optimization
Targeted therapies

Multiple studies evaluating novel drug combinations and personalized treatment approaches for various breast cancer subtypes.

02 Gastrointestinal Oncology

Innovative research in colorectal cancer and pancreatic cancer, exploring new treatment combinations and maintenance therapies.

First-line treatments
Maintenance strategies
Targeted therapeutic approaches

Studies focus on improving survival rates and treatment effectiveness for advanced gastrointestinal cancers.

03 Gynecologic Oncology

Research targeting ovarian cancer and related conditions, with emphasis on platinum-sensitive diseases and novel therapeutic combinations.

Maintenance treatments
Combination therapies
Treatment optimization

Trials exploring new approaches for treating various types of gynecologic cancers with innovative drug combinations.

Back to Italy All countries

Clinical trials in Prato – page 38

885 trials in Prato

Sjogren's syndrome

Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Sjogren's syndrome

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

Cardiovascular disorder

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Squamous cell carcinoma of head and neck

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Vitiligo

A Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is

Migraine

Study of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks

Migraine

Study of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients

Psoriasis

Study of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis

Hidradenitis

Long-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa

Migraine

Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Dementia Alzheimer's type

Study of VHB937 to evaluate its effects on cognition and function in people with early Alzheimer's Disease over 72 weeks

Obesity+1

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Filter the trials

Other cities in Italy

Clinical research in Prato

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Clinical trials in Prato – page 38

885 trials in Prato

Obesity+1

Other cities in Italy

Related

Clinical research in Prato

Prefer not to search on your own, or looking for clinical trials for a rare disease?